NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Introduction GCH1 has been implicated in Parkinson’s disease (PD), but its risks variants and associations are not well defined. Objectives To investigate the clinical relevance and PD risk associated with the GCH1 p.Ser80Asn variant. Methods We first identified a segregating GCH1 p.Ser80Asn variant in a Malaysian Chinese PD family via whole genome sequencing (WGS). We assessed its risk association using multi-ancestry WGS data from the Global Parkinson’s Genetics Program (GP2) (n=22,372 PD vs n=8,826 Controls ) and meta-analysis of East Asian (EAS) cohorts (n=4,712 PD vs 38,733 Controls ). Clinico-demographic details of affected variant carriers were collated. Results The GCH1 p.Ser80Asn variant was enriched in GP2 EAS PD populations (n=9/2,757; 0.33%) but not detected in other ancestries. Meta-analysis revealed increased PD risk in EAS populations (odds ratio:5.1; 95%CI:2.3–10.7; p=2.89×10 −5 ). Affected carriers (mean age at onset:56.3±12.5 years) had additional occurrence of dystonia, while dementia was rare. Conclusions The GCH1 p.Ser80Asn variant is a rare, EAS-enriched risk variant for PD.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.